Bardet–Biedl Syndrome (BBS) is a rare multisystem ciliopathy
with striking phenotypic and genetic heterogeneity. Ophthalmic manifestations,
particularly rod–cone dystrophy resembling retinitis pigmentosa, often provide
the earliest diagnostic clue and serve as a gateway to systemic evaluation.
Beyond ocular findings, the syndrome encompasses obesity, polydactyly,
hypogonadism, renal dysfunction, and developmental or cognitive impairment,
necessitating coordinated multidisciplinary care. This chapter presents an
atypical paediatric case of BBS with retinitis pigmentosa sine pigmento,
central obesity, polydactyly, dental anomalies, and genital hypoplasia,
illustrating the spectrum of clinical variability. Recent advances in molecular
genetics have expanded the BBS gene spectrum, with the recent discovery of
IFT57 further linking intraflagellar transport dysfunction to disease
pathogenesis. Current management remains largely supportive, focusing on
low-vision rehabilitation and systemic surveillance; however, emerging
interventions such as gene augmentation, gene editing, pharmacological agents
like setmelanotide, and neuroprotective strategies hold promise for disease
modification. By integrating case findings with updated molecular insights,
therapeutic advances, and future directions, this chapter highlights the
central role of ophthalmologists in early recognition and long-term management
of BBS.
Author(s) Details
Ruchi Shukla
Department of Ophthalmology, AIIMS Raebareli, India.
Pragati Garg
Department of Ophthalmology, AIIMS Raebareli, India.
Ashutosh Kumar Mishra
Department of Neurology, AIIMS Raebareli, India.
Nilakshi Banerjee
Department of Ophthalmology, AIIMS Raebareli, India.
Please see the book here :- https://doi.org/10.9734/bpi/msraa/v11/6335
No comments:
Post a Comment